Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Manchester University NHS Foundation Trust
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
The patient is aged 18 years or older.
Diagnosis on core needle biopsy of invasive cancer of the breast
Unifocal invasive tumour on imaging (hormone receptor positive or negative)
T1 or T2 primary or locally recurrent tumour measuring ≤25mm on imaging, excluding any adjacent ductal carcinoma in situ (largest of the measurements on mammography (including digital breast tomosynthesis if performed) and ultrasound)
The tumour is clearly visible on ultrasound
Vacuum-assisted excision of the entire ultrasonically visible tumour is deemed to be technically feasible
The patient is considered to be at high risk of complications or death from a general anaesthetic and therefore surgery under general anaesthesia is not considered appropriate. This must be confirmed by agreement by two named consultant breast surgeons, a multidisciplinary team meeting (including at least one consultant breast surgeon) or by formal anaesthetic assessment. Unsuitability for surgery under local anaesthetic must be confirmed by a consultant breast surgeon.
or - The patient refuses to undergo surgery. This must be confirmed by a consultant surgeon and breast care nurse following full discussion of the treatment options.
or - The patient is considered unlikely to benefit from surgical removal of the cancer by virtue of known metastatic disease or other life-shortening condition. This must be confirmed by discussion in a multidisciplinary team meeting which includes an oncologist.
You may not be if
The patient is on anticoagulants or has a known clotting disorder
Pregnancy or lactation
Allergy to local anaesthetic
Clareo Health | A Pilot Study of Ultrasound-guided Vacuum-assisted Excision of Breast Cancers
